A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have been treated for early-stage ...
May 25, 2017
0
0
A new analysis indicates that many cancer survivors change their prescription drug use (including skipping doses or requesting cheaper medications) for financial reasons. Published early online in Cancer, a peer-reviewed ...
Feb 20, 2017
0
1
Cancer patients are ending up in debt because they have to cover the costs of treatment as well as other care related expenses, researchers report at the ESMO Asia 2016 Congress in Singapore.
Dec 17, 2016
0
1
Financial difficulties can significantly impact a cancer patient's quality of life during treatment and may even increase their risk of death, according to the results of a pooled analysis presented at the ESMO 2016 Congress ...
Oct 11, 2016
0
0
Some of the current fixes aimed at reducing the financial burden of chronic illness—including the ability to enroll in a health care plan under the Affordable Care Act—are not enough to save those with diabetes from the ...
Jun 1, 2016
0
153
Study also reveals substantial heath and healthcare issues for uninsured children and financial burden on families.
Mar 22, 2016
0
4
An analysis of US data from 2011 indicates that nearly 29 percent of cancer survivors are financially burdened as a result of their cancer diagnosis and/or treatment. Published early online in Cancer, a peer-reviewed journal ...
Mar 14, 2016
0
3
The majority of patients with locally advanced head and neck cancers (LAHNC) rely on cost-coping strategies that alter their lifestyle in order to manage the financial burden of their care, according to research presented ...
Feb 18, 2016
0
0
Cancer can cause an enormous financial burden for some patients. Now a new study finds the burden is worse for patients without paid sick leave.
Dec 22, 2015
0
0
The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...
Apr 21, 2015
0
21
